Study of Combination Therapy With LdT Plus Adefovir Versus Adefovir Alone
- Status
- TERMINATED
- Phase
- PHASE3
Clinical Trials Related to Hepatitis B
Related studies linked through entity extraction aliases.
To Evaluate Immunogenicity & Safety of GSK Bio's DTPa-HBV-IPV/Hib (Mixed Vaccine) and DTPa-IPV/Hib + HBV Vaccines
- Status
- COMPLETED
- Phase
- PHASE3
Safety and Efficacy Study of Retreated Clevudine in Chronic HBV Patients Who Received Clevudine in L-FMAU-201
- Status
- TERMINATED
- Phase
- PHASE2
Durability of Antiviral Activity in Chronic HBV Patients Who Showed Complete Response in L-FMAU-301,302 or 303 Trial
- Status
- COMPLETED
- Phase
- N/A
Compare the Efficacy and Safety of 48-week Treatment With Clevudine 30mg Versus Lamivudine 100mg for CHB Infection
- Status
- COMPLETED
- Phase
- PHASE3
Safety and Antiviral Activity of Clevudine in Patients Who Have Completed the L-FMAU-301 or L-FMAU-302 Trials
- Status
- TERMINATED
- Phase
- PHASE3
Study of PR5I, a Pediatric Combination Vaccine With Enhanced Hepatitis B Component Given Concomitantly With Prevnar®
- Status
- COMPLETED
- Phase
- PHASE2
Comparison of DTaP-IPV-Hep B-PRP~T Combined Vaccine to CombAct-HIB® Concomitantly Given With Engerix B® Paediatric and OPV
- Status
- COMPLETED
- Phase
- PHASE3
Persistence of the Immune Response to Hepatitis B in 7-9 Years Old Children Previously Vaccinated With DTPa-HBV-IPV/Hib
- Status
- COMPLETED
- Phase
- PHASE4
Immunogenicity & Safety Study of Combined/Separate Vaccine(s) Against Common Diseases in Infants (2,4,6 Months of Age).
- Status
- COMPLETED
- Phase
- PHASE3
Study Comparing a DTaP-HB-PRP~T Combined Vaccine With Tritanrix HepB/Hib™, Concomitantly With OPV in Healthy Infants
- Status
- COMPLETED
- Phase
- PHASE3
Immuno & Safety Study of GSK Biologicals' Thio or Preservative Free Hepatitis B Vaccine in Subjects Aged 11-15 Yrs
- Status
- COMPLETED
- Phase
- PHASE3
Comparison of DTaP-HB-PRP~T Combined Vaccine to Tritanrix-HepB/Hib™, Both Given Concomitantly With Oral Polio Vaccine
- Status
- COMPLETED
- Phase
- PHASE3
Persistence of the Immune Response to Hepatitis B in 4-6 Years Old Children Previously Vaccinated With DTPa-HBV-IPV/Hib
- Status
- COMPLETED
- Phase
- PHASE4
Assess Immunogenicity, Reactogenicity, Safety of a Booster of GSK Biologicals DTPw-HBV/Hib Kft Compared to DTPw-HBV/Hib
- Status
- COMPLETED
- Phase
- PHASE3
Evaluate Immune Response Approximately 5 to 6 Years After Receiving Different Formulations of GSK Bio Hep B Vaccine
- Status
- COMPLETED
- Phase
- PHASE4
Modified Process Hepatitis B Vaccine in Healthy Neonates (V232-056)
- Status
- COMPLETED
- Phase
- PHASE2
Compare Immunogenicity & Safety of 2 Formulations of GSK Biologicals' DTPa-HBV-IPV/Hib Vaccine Given in Healthy Infants
- Status
- COMPLETED
- Phase
- PHASE3
Safety Study of a Vaccine Against Meningitis in Infants (2,4 & 6 Months Age) After a Birth Dose of Hepatitis B.
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Assess Antibody Persistence, Boostability & Safety in Previously Primed Subjects.
- Status
- COMPLETED
- Phase
- PHASE2